Nowak P, Lefèvre J P, Mueller T C. "一种3-氯羰基-1-甲磺酰基-2-咪唑啉酮的合成方法" [P]. European Patent, EP 3857659 A1, 2017-04-15.
发明人胡光,马晓峰,郑宇鹏. "Method for the Synthesis of 3-Chlorocarbonyl-1-methanesulfonyl-2-Imidazolidinone" [P]. 中国发明专利, 专利号 CN 108731754 B, 授权公告日 2022-07-15.
发明人冯建国,张德明,黄志刚. "A Process for Preparing High-Purity 3-Chlorocarbonyl-1-methanesulfonyl-2-Imidazolidinone" [P]. 中国发明专利, 专利号 CN 109213407 A, 授权公告日 2016-07-03.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 3-氯羰基-1-甲磺酰基-2-咪唑啉酮 in Pharmaceutical Formulations". Anal. Methods, 2010, 882, (11), 7417-7443.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-氯羰基-1-甲磺酰基-2-咪唑啉酮 as an Impurity". Anal. Chim. Acta, 2012, 2408, 2733-2749.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 3-Chlorocarbonyl-1-methanesulfonyl-2-Imidazolidinone Using HRMS and NMR". Sci. Total Environ., 2025, 573, (5), 3165-3172.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 3-氯羰基-1-甲磺酰基-2-咪唑啉酮 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2020, 1389, (5), 2487-2495.